Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
M. Yu. Nadinskaia(Sechenov University), Е. Б. Зуева(Tashkent Medical Academy), Kh. B. Kodzoeva(Sechenov University), Akzhan Konysbekova(Kazakh Institute of Oncology and Radiology), Jamilya Kaibullayeva(Kazakh National Medical University), F. I. Khamrabaeva(Tashkent Pediatric Medical Institute), М. V. Maevskaya(Sechenov University), A. Raissova(Kazakh Scientific Research Veterinary Institute), В. Т. Ивашкин(Institute of Electronic Measurements KVARZ (Russia)), И. Ю. Пирогова(Chelyabinsk Regional Clinical Oncology Center), Evgeny Chesnokov(Tyumen State Medical University), Alexander Nersesov(Kazakh National Medical University)
Cited by 68
Related Papers
The Concept of Folic Acid in Health and Disease
|Molecules|2021|284
Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses
|Clinical Gastroenterology and Hepatology|2022|271
RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. CLINICAL GUIDELINES
|Rheumatology Science and Practice|2018|151
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease
|Cochrane Database of Systematic Reviews|2015|143